• Explore /
  • Poster
  • / Quadruplet regimen with capecitabine, irinotecan, oxaliplatin, and bevacizumab in chemo-naive patients with metastatic colorectal cancer: Results from the safety lead-in of QUATTRO-II study.

Quadruplet regimen with capecitabine, irinotecan, oxaliplatin, and bevacizumab in chemo-naive patients with metastatic colorectal cancer: Results from the safety lead-in of QUATTRO-II study.

Abstract Poster

Authors

null

Hideaki Bando

Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

Hideaki Bando , Daisuke Kotani , Masahito Kotaka , Akihito Kawazoe , Toshiki Masuishi , Hironaga Satake , Hiroya Taniguchi , Kentaro Yamazaki , Takeharu Yamanaka , Eiji Oki , Takayuki Yoshino , Kei Muro , Yoshito Komatsu , Takeshi Kato , Akihito Tsuji

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Colorectal Cancer

Track

Colorectal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04097444

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 57)

DOI

10.1200/JCO.2021.39.3_suppl.57

Abstract #

57

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Akihito Tsuji

First Author: Hideaki Bando

First Author: Patrick M Boland

First Author: Antoine Adenis